Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Raia Drogasil S.A.
  6. Summary
    RADL3   BRRADLACNOR0

RAIA DROGASIL S.A.

(RADL3)
  Report
End-of-day quote. End-of-day quote Bolsa de Valores de Sao Paulo - 12/03
22.82 BRL   +2.65%
11/16RAIA DROGASIL S.A. : Ex-dividend day for
FA
11/16RAIA DROGASIL S.A. : Ex-dividend day for interim dividend
FA
11/09Tranche Update on Raia Drogasil S.A.'s Equity Buyback Plan announced on November 9, 2021.
CI
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Valores De Sao P…
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
22.61 22.38 21.81 22.23 22.82 Last
6570900 15664300 7159200 8356900 5328900 Volume
-0.22% -1.02% -2.55% +1.93% +2.65% Change
Estimated financial data (e)
Sales 2021 24 198 M 4 281 M 4 281 M
Net income 2021 856 M 151 M 151 M
Net Debt 2021 859 M 152 M 152 M
P/E ratio 2021 44,3x
Yield 2021 0,55%
Sales 2022 28 212 M 4 991 M 4 991 M
Net income 2022 1 065 M 188 M 188 M
Net Debt 2022 708 M 125 M 125 M
P/E ratio 2022 35,4x
Yield 2022 0,78%
Capitalization 37 588 M 6 647 M 6 650 M
EV / Sales 2021 1,59x
EV / Sales 2022 1,36x
Nbr of Employees 48 481
Free-Float 66,8%
More Financials
Company
Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in... 
Sector
Drug Retailers
Calendar
03/02Earnings Release
More about the company
Ratings of Raia Drogasil S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about RAIA DROGASIL S.A.
11/16RAIA DROGASIL S.A. : Ex-dividend day for
FA
11/16RAIA DROGASIL S.A. : Ex-dividend day for interim dividend
FA
11/09Tranche Update on Raia Drogasil S.A.'s Equity Buyback Plan announced on November 9, 202..
CI
11/09Raia Drogasil S.A. announces an Equity Buyback for 3,000,000 shares.
CI
10/28Presentation - RD Day 2021
PU
09/30Raia Drogasil S.A.'s Equity Buyback announced on November 9, 2021, has closed with 3,00..
CI
09/03RAIA DROGASIL S.A.(BOVESPA : RADL3) dropped from Brazil IBRX 50 Index
CI
08/10Raia Drogasil S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/10Raia Drogasil S.A. agreed to acquire CUCO Health app from Dr. CUCO.
CI
08/10Raia Drogasil S.A. authorizes a Buyback Plan.
CI
06/24RAIA DROGASIL S.A. : Ex-dividend day for
FA
05/11Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
05/11RAIA DROGASIL S.A. : 1st quarter report
CO
04/01Raia Drogasil S.A. completed the acquisition of B2U Editora S.A. for BRL 38.7 million.
CI
03/12RAIA DROGASIL S.A. : Ex-dividend day for
FA
More news
News in other languages on RAIA DROGASIL S.A.

- No features available -

More news
Chart RAIA DROGASIL S.A.
Duration : Period :
Raia Drogasil S.A. Technical Analysis Chart | RADL3 | BRRADLACNOR0 | MarketScreener
Technical analysis trends RAIA DROGASIL S.A.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 22,82 BRL
Average target price 27,44 BRL
Spread / Average Target 20,2%
EPS Revisions
Managers and Directors
Marcílio D'Amico Pousada Chief Executive Officer
Antonio Carlos Coelho Vice President-Finance & Administration
Antonio Carlos Pipponzi Chairman
Marco Ambrogio Crespi Bonomi Independent Director
Sylvia de Souza Leão Wanderley Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RAIA DROGASIL S.A.-8.87%6 647
AIN HOLDINGS INC.-2.83%1 928
RITE AID CORPORATION-27.23%650
PETMED EXPRESS, INC.-15.25%547
QOL HOLDINGS CO., LTD.20.00%438
HLS THERAPEUTICS INC.-17.94%374